Prostate Cancer - Results from #20660

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: A post hoc analysis of the randomized FinnProstate Study VII - Abstract May 1, 2014

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-Year follow-up of the ARO 96-02/AUO AP 09/95 trial - Abstract May 1, 2014

Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: Decreased likelihood of finding significant cancer on future biopsy - Abstract May 1, 2014

Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative - Abstract May 1, 2014

OncoGenex announces top-line survival results of phase 3 SYNERGY trial evaluating custirsen for metastatic castrate-resistant prostate cancer April 30, 2014

Detection of circulating tumor cells from peripheral blood in prostate cancer - Abstract April 30, 2014

Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival - Abstract April 30, 2014

Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients - Abstract April 30, 2014

Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer - Abstract April 30, 2014

Preservation of the internal vesical sphincter and proximal urethra during retropubic radical prostatectomy may improve earlier recovery of continence in selected patients - Abstract April 30, 2014

Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: Results from Japanese Observational Cohort - Abstract April 30, 2014

Coffee consumption and urologic cancer risk: A meta-analysis of cohort studies - Abstract April 30, 2014

Navigating healthcare: A qualitative study exploring prostate cancer patients' and doctors' experience of consultations using a decision-support intervention - Abstract April 30, 2014

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer - Abstract April 30, 2014

Prognosis related to metastatic burden measured by 18F-fluorocholine PET/CT in castration-resistant prostate cancer - Abstract April 30, 2014

Usage, effectiveness and safety of abiraterone in prostate cancer - Abstract April 29, 2014

Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: New and emerging treatment options - Abstract April 29, 2014

Biopsy strategies for selecting patients for focal therapy for prostate cancer - Abstract April 29, 2014

Molecular lymph node staging in prostate and bladder cancer - Abstract April 29, 2014

DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy - Abstract April 29, 2014

Page 1034 of 1436